Overview

Watch our video to hear how the Pharma Pollution Hub is working to find solutions.

The Pharma Pollution Hub is an independent, non-profit think tank based at the University of Exeter.

We have created a Consortium of key stakeholders and thought leaders from across society to reduce pharmaceutical pollution.

Our initial call-to-action paper mapped out the UK healthcare pharmaceutical pollution system to identify leverage points and recommendations for action.

These recommendations will be published as a Roadmap for Action and a Research for Change Agenda in 2024.

Our Aims

We are using a systems thinking approach with three clear aims:

1. Define the problem

We are raising awareness of the environmental impacts of pharmaceuticals used in healthcare, and outlining the social, economic and human health risks of not taking action.


2. Mobilise the research community to accelerate change

We are developing a Research for Change Agenda, to focus the expertise and resources of the academic community to answer the questions that will support our transition to a sustainable pharmaceutical society.


3. Collectively identify pragmatic solutions

We are working with thought leaders from across the public health, pharmaceutical, healthcare and environmental sectors, to co-design an actionable Roadmap for Action.

OUR MISSION

We are dedicated to finding solutions to reduce the environmental impact of medicines used in UK healthcare.

OUR APPROACH

We are collectively driving change through a systems thinking, collaborative approach.

OUR PEOPLE

We have created a Consortium of stakeholders and thought leaders from across society.

OUR AIMS

We are dedicated to finding solutions to reduce the environmental impact of medicines used in UK healthcare.

OUR SCOPE

We have created five interlinked working groups, focused on specific areas of the healthcare pharmaceutical life cycle.

OUR OUTPUTS

We have mapped out the UK healthcare pharmaceutical system to inform our Roadmap for Action and Research for Change Agenda.